Catalyst Wire Dossier Catalyst Wire Dossier

Antisense Oligonucleotide Eye Drops

· Eye & ENT Hospital of Fudan University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Antisense Oligonucleotide Eye Drops, covering 2024-06-11 to 2024-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis [EARLY_Phase 1]

See pricing